Skip to main content

Abstract

The prevalence of chronic kidney disease (CKD) in the USA is nearly 15%; Medicare spends nearly $114 billion on patients with CKD and end stage renal disease (ESRD) with a large proportion of this money going to access related complications. The National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-KDOQI) publishes clinical practice guidelines for vascular access with the aim to improve outcomes in dialysis. The main initiatives are to increase autogenous access use and protect existing accesses. The Centers for Medicare and Medicaid services Fistula First Breakthrough Initiative (FFBI) (2005) pushes for the use of autogenous fistulas in patients and through these initiatives have been making strides toward reducing catheter use and catheter related complications. However, the prevalence of autogenous access has plateaued at around 60%, and as many as 80% of new dialysis patients are still initiating dialysis with a catheter. Most recently the initiative changed to Fistula First Catheter Last (FFCL) noting that autogenous access is not feasible in all patients and pushing for prosthetic graft use over catheters. Although vascular surgeons are not the first to encounter dialysis patients, we play a key role in eliminating barriers to reliable access including facilitating entry into vascular clinics, establishing reliable access, and remaining vigilant to potentially failing accesses. The SVS published clinical practice guidelines in 2008 for the surgical placement and maintenance of hemodialysis access encompassing timing of referral, operative strategies, monitoring and surveillance, and management of malfunctioning and failed access. In this chapter we review the evaluation of an access patient, selection of location and type of access as well as some common pitfalls and complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Sidway AN, Spergel LM, Besarb A, et al. Clinical practice guidelines for the placement and maintenance of arterio-venous hemodialysis access. J Vasc Surg. 2008;48:2S–25S.

    Article  Google Scholar 

  2. Lazarides MK, Georgiadis GS, Antonio GA, Staramos DN. A meta-analysis of dialysis access outcomes in elderly patients. J Vasc Surg. 2007;45:420–6.

    Article  PubMed  Google Scholar 

  3. Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J of Kid Disease. 2001;38(3):560–4.

    Article  CAS  Google Scholar 

  4. Konner K, Hulbert-Shearon TE, Royrs EC, Port FK, Tailoring the initial vascular access for dialysis patients. Kidney Int. 2002;62:329–38.

    Article  PubMed  Google Scholar 

  5. Wetzig GA, Cough IR, Furnival CM. One hundred cases of arteriovenous fistula for hemodialysis access: the effect of cigarette smoking on patency. Aust NZ J Surg. 1985;55:551–4.

    Article  CAS  Google Scholar 

  6. Saran R, Dykstra DM, Wofe RA, Gillespie B, Held PJ, Young EW. Association between vascular access failure and the use of specific drugs: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2002;40:1255–63.

    Article  CAS  PubMed  Google Scholar 

  7. Yevzlin AS, Conely EL, Sanchez RJ, Young HN, Becker BN. Vascular access outcomes and medication use: a USRDS study. Semin Dial. 2006;19(6):535–9.

    Article  PubMed  Google Scholar 

  8. Jackson RS, Sidway AN, Amdur RL, Khetarpal A, Macsata RA. Angiotensin receptor blocker and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement. J Vasc Surg. 2011;54:1706–12.

    Article  PubMed  Google Scholar 

  9. Silva MB, Hobson RW, Pappas PJ, et al. A strategy for increasing the use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998;27(2):302–8.

    Article  PubMed  Google Scholar 

  10. Mendez RR, Farber MA, Marston WA, Dinwiddie LC, Keagy BA, Burnham SJ. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg. 2002;36(3):460–3.

    Article  Google Scholar 

  11. Huber T, Ozaki C, Flynn TC, et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg. 2002;36(3):452–9.

    Article  PubMed  Google Scholar 

  12. Arroyo MR, Sideman MJ, Spergel L, Jennings WC. Primary and staged transposition arteriovenous fistulas. J Vas Surg. 2008;47:1279–83.

    Article  Google Scholar 

  13. Choe HM, Lal B, Cerveira JJ, et al. Durability and cumulative functional patency of transposed and non-transposed arteriovenous fistulae. J Vasc Surg. 2003;38(6):1206–12.

    Article  Google Scholar 

  14. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38(5):1005–11.

    Article  PubMed  Google Scholar 

  15. Glickman MH, Burgess J, Cill D, et al. Prospective multi-center study with 1-year analysis of new vascular grafts used for early cannulation in patients undergoing hemodialysis. J Vasc Surg. 2015;62:434–41.

    Article  PubMed  Google Scholar 

  16. Patel ST, Hughes J, Mills JL. Failure of arteriovenous fistula maturation: an unintended consequence of seeing dialysis outcome quality initiative guidelines for hemodialysis access. J Vasc Surg. 2003;38(3):439–45.

    Article  PubMed  Google Scholar 

  17. McLafferty RB, Pryor RW, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vas Surg. 2007;45(5):981–5.

    Article  Google Scholar 

  18. Dember LM, Holmberg EF, Kaufman JS. Value of static venous pressure for predicting arteriovenous graft thrombosis. Kidney Int. 2002;61(5):1899–904.

    Article  PubMed  Google Scholar 

  19. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis. 2001;37:S137–81.

    Google Scholar 

  20. Weitzel WF, et al. Analysis of variable flow Doppler hemodialysis access flow measurements and comparison with ultrasound dilution. Am J Kidney Dis. 2001;38(5):935–40.

    Article  CAS  PubMed  Google Scholar 

  21. Hassell DH, et al. Optimizing dialysis dose by increasing blood flow rate in patients with reduced vascular-access flow rate. Am J Kidney Dis. 2001;38(5):948–55.

    Article  CAS  PubMed  Google Scholar 

  22. Powell S, Chan T. Augmented balloon-assisted maturation (BAM) for non-maturing dialysis arteriovenous fistula. J Vasc Access. 2011;12(1):9–12.

    Article  Google Scholar 

  23. Anaya-Ayala JE, et al. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients. J Vasc Surg. 2011;54(3):754–9.

    Article  PubMed  Google Scholar 

  24. Kim CY, et al. Analysis of infection risk following covered stent exclusion of pseudoaneurysm in prosthetic arteriovenous hemodialysis access grafts. J Vasc Interv Radiol. 2012;23(1):69–74.

    Article  PubMed  Google Scholar 

  25. Shatsky JB, et al. Single-center experience with the arrow-Trerotola percutaneous thrombectomy device in the management of thrombosed native dialysis fistulas. J Vasc Interv Radiol. 2005;16(2):1605–11.

    Article  PubMed  Google Scholar 

  26. Vogel PM, Bansal V, Marshall MW. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activation or urokinase compared to mechanical thrombolysis with the arrow-Trerotola percutaneous thrombolytic device. J Vasc Interv Radiol. 2001;12(10):1157–65.

    Article  CAS  PubMed  Google Scholar 

  27. KDOQI guidelines 2006 updates. http://www.kidney.org/progessionals/kdoqi/guideline_uphd_pd

  28. Bos MJ, Koudstaal PJ, Hofman A, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam study. Stroke. 2007;38(12):3127–32.

    Article  PubMed  Google Scholar 

  29. Cases A, Escolar G, Reverter JC, et al. Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int. 1992;42(3):668–72.

    Article  CAS  PubMed  Google Scholar 

  30. Gawaz MP, Dobs G, Spath M, Schollmeyer P, Gurland HJ, Mujais SK. Impaired function of platelet membrane glycoprotein IIb/IIIa in end-stage renal disease. J Am Soc Nephrol. 1994;5(1):36–46.

    Article  CAS  PubMed  Google Scholar 

  31. Livio M, Mannucci PM, Vigano G, et al. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med. 1986;315(12):731–5.

    Article  CAS  PubMed  Google Scholar 

  32. Mailloux LU, et al. Mortality in dialysis patients: analysis of the cause of death. Am J Kidney Dis. 1991;19:326–35.

    Article  Google Scholar 

  33. Churchill D, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.

    Article  CAS  PubMed  Google Scholar 

  34. Stevenson KB, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of the KKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–55.

    Article  PubMed  Google Scholar 

  35. Barshes NR, et al. Endovascular repair of hemodialysis graft-related pseudoaneurysm: an alternative treatment strategy in salvaging failing dialysis access. Vasc Endovasc Surg. 2008;42:228–34.

    Article  Google Scholar 

  36. Moszkowicz A, et al. Occlusion of rapidly expanding hemodialysis graft with placement of a stent graft. Semin Interv Radiol. 2007;24:34–7.

    Article  Google Scholar 

  37. Florescu MC, et al. Endovascular treatment of arteriovenous graft pseudoaneurysms, indications, complications and outcomes: a systematic review. Hemodial Int. 2014;18:785–92.

    Article  PubMed  Google Scholar 

  38. Surowiec SM, Fegley AJ, Tanski WJ, et al. Endovascular management of central venous stenosis in the hemodialysis patients: restyle of percutaneous therapy. Vasc Endovasc Surg. 2004;38(4):249–354.

    Article  Google Scholar 

  39. Papasavas PK, Reifsnyder T, Birdas TJ, Caushaj PF, Leers S. Prediction of arteriovenous access steal syndrome utilizing digital pressure measurements. Vasc Endovasc Surg. 2003;37(3):179–84.

    Article  Google Scholar 

  40. Morsy AH, Kulbaski M, Chen C, Isiklar H, Lundsmen AB. Incidence and characteristics of patients with hand ischemia after hemodialysis access procedure. J Surg Res. 1998;74(1):8–10.

    Article  CAS  PubMed  Google Scholar 

  41. Sidway AN, Gray R, Besarb A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603–10.

    Article  Google Scholar 

  42. Goff CD, Sato DT, Bloch PH, et al. Steal syndrome complicating hemodialysis access procedures: can it be predicted? Ann Vasc Surg. 2000;14(2):138–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beatriz Valdovinos Leong .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leong, B.V., Teruya, T.H. (2023). Vascular Access. In: Murga, A., Teruya, T.H., Abou-Zamzam Jr, A.M., Bianchi, C. (eds) The Vascular Surgery In-Training Examination Review (VSITE). Springer, Cham. https://doi.org/10.1007/978-3-031-24121-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-24121-5_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-24120-8

  • Online ISBN: 978-3-031-24121-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics